Nan Fung Group Holdings LTD Cabaletta Bio, Inc. Transaction History
Nan Fung Group Holdings LTD
- $86 Million
- Q2 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 47,150 shares of CABA stock, worth $200,859. This represents 0.41% of its overall portfolio holdings.
Number of Shares
47,150
Previous 47,150
-0.0%
Holding current value
$200,859
Previous $804,000
56.22%
% of portfolio
0.41%
Previous 0.8%
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
145Shares Held
50.1MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$23.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$20.3 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$16.5 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12.9 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.2 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $124M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...